Mesenchymal Stem Cells for Immune Non-responder Patients With HIV Infection
Clinical trial NCT05872659 · UNKNOWN
Trial details
- NCT number
- NCT05872659
- Sponsor
- Shandong Qilu Cell Therapy Engineering Technology Co., Ltd
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-16
- Primary completion
- 2025-11-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.